David Stegner

Dr. David Stegner

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
MMMohsen Malehmir
Mohsen Malehmir
DPDominik Pfister
Dominik Pfister
SGSuchira Gallage
Suchira Gallage
MSMarta Szydlowska
Marta Szydlowska
DIDonato Inverso
Donato Inverso
MHMathias Heikenwälder
Mathias Heikenwälder

20 October 2009 in Science Signaling
Verified
Journal Article
Closed access
PDF file
ABAlejandro Berna
Alejandro Berna
ABAttila Braun
Attila Braun
RKRobert Kraft
Robert Kraft
CKChristoph Kleinschnitz
Christoph Kleinschnitz
MSMichael K. Schuhmann
Michael K. Schuhmann
BNBernhard Nieswandt
Bernhard Nieswandt
Excessive cytosolic calcium ion (Ca2+) accumulation during cerebral ischemia triggers neuronal cell death, but the underlying mechanisms are poorly understood. Capacitive Ca2+ entry (CCE) is a process whereby depletion of intracellular Ca2+ stores causes the activation of plasma membrane Ca2+ channels. In nonexcitable cells, CCE is controlled by the endoplasmic reticulum (ER)–resident Ca2+ sensor STIM1, whereas the closely related protein STIM2 has been proposed to regulate basal cytosolic and ER Ca2+ concentrations and make only a minor contribution to CCE. Here, we show that STIM2, but not STIM1, is essential for CCE and ischemia-induced cytosolic Ca2+ accumulation in neurons. Neurons from Stim2−/− mice showed significantly increased survival under hypoxic conditions compared to neurons from wild-type controls both in culture and in acute hippocampal slice preparations. In vivo, Stim2−/− mice were markedly protected from neurological damage in a model of focal cerebral ischemia. These results implicate CCE in ischemic neuronal cell death and establish STIM2 as a critical mediator of this process.

1 July 2013 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
CDCarsten Deppermann
Carsten Deppermann
DCDeya Cherpokova
Deya Cherpokova
PNPaquita Nurden
Paquita Nurden
JSJan-Niklas Schulz
Jan-Niklas Schulz
ITIna Thielmann
Ina Thielmann
BNBernhard Nieswandt
Bernhard Nieswandt
Platelets are anuclear organelle-rich cell fragments derived from bone marrow megakaryocytes (MKs) that safeguard vascular integrity. The major platelet organelles, α-granules, release proteins that participate in thrombus formation and hemostasis. Proteins stored in α-granules are also thought to play a role in inflammation and wound healing, but their functional significance in vivo is unknown. Mutations in NBEAL2 have been linked to gray platelet syndrome (GPS), a rare bleeding disorder characterized by macrothrombocytopenia, with platelets lacking α-granules. Here we show that Nbeal2-knockout mice display the characteristics of human GPS, with defective α-granule biogenesis in MKs and their absence from platelets. Nbeal2 deficiency did not affect MK differentiation and proplatelet formation in vitro or platelet life span in vivo. Nbeal2-deficient platelets displayed impaired adhesion, aggregation, and coagulant activity ex vivo that translated into defective arterial thrombus formation and protection from thrombo-inflammatory brain infarction following focal cerebral ischemia. In a model of excisional skin wound repair, Nbeal2-deficient mice exhibited impaired development of functional granulation tissue due to severely reduced differentiation of myofibroblasts in the absence of α-granule secretion. This study demonstrates that platelet α-granule constituents are critically required not only for hemostasis but also thrombosis, acute thrombo-inflammatory disease states, and tissue reconstitution after injury.

7 November 2010 in Journal of Molecular Medicine
Verified
Journal Article
Closed access
PDF file
DSDavid Stegner
David Stegner
BNBernhard Nieswandt
Bernhard Nieswandt

5 January 2010 in Science Signaling
Verified
Journal Article
Closed access
PDF file
MEMargitta Elvers
Margitta Elvers
DSDavid Stegner
David Stegner
IHIna Hagedorn
Ina Hagedorn
CKChristoph Kleinschnitz
Christoph Kleinschnitz
ABAttila Braun
Attila Braun
BNBernhard Nieswandt
Bernhard Nieswandt
Platelet aggregation is essential for hemostasis but can also cause myocardial infarction and stroke. A key but poorly understood step in platelet activation is the shift of the principal adhesive receptor, αIIbβ3 integrin, from a low- to high-affinity state for its ligands, a process that enables adhesion and aggregation. In response to stimulation of heterotrimeric guanosine triphosphate–binding protein or immunoreceptor tyrosine-based activation motif–coupled receptors, phospholipases cleave membrane phospholipids to generate lipid and soluble second messengers. An essential role in platelet activation has been established for phospholipase C (PLC) but not for PLD and its product phosphatidic acid. Here, we report that platelets from Pld1−/− mice displayed impaired αIIbβ3 integrin activation in response to major agonists and defective glycoprotein Ib–dependent aggregate formation under high shear conditions. These defects resulted in protection from thrombosis and ischemic brain infarction without affecting tail bleeding times. These results indicate that PLD1 may be a critical regulator of platelet activity in the setting of ischemic cardiovascular and cerebrovascular events.

1 May 2014 in Thrombosis Research
Verified
Journal Article
Closed access
DSDavid Stegner
David Stegner
SDSebastian Dütting
Sebastian Dütting
BNBernhard Nieswandt
Bernhard Nieswandt